Based on these observations, pre-clinical laboratory tests with CLL cells were performed, and these cells showed toxicity of danazol against CD19+/CD5+ cells at concentrations above 3 μM, and the optimal concentration was 10 μM [19]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.